A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus

NCT00254254 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Exenatide - Exenatide - Placebo
DRUG: Exenatide - Placebo - Exenatide
DRUG: Placebo - Exenatide - Exenatide

Sponsor

AstraZeneca

Collaborators

[object Object]